Julianne Bruno, Chief Operating Officer at CRISPR Therapeutics AG (CRSP), sold 333 shares at $52.80 ($18K) on 2025-02-19, disclosed to the SEC on 2025-02-19.
Open-market sale of $18k CRSP by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CRSP | SELL | 2024-06-24 | $378K | — | Filing → |